A large international study led by researchers at Memorial Sloan Kettering has immediate clinical relevance for risk assessment and treatment of people with myelodysplastic syndrome and acute myeloid leukemia.
- NASA finds Tropical Storm Dolphin going swimmingly
- Regulatory T cells could lead to new immunotherapies aimed at treating multiple sclerosis
- Children with COVID-19 show different immune responses, but better outcomes than adults
- Evaluating impacts of COVID-19 lockdowns on children and young people
- Modeling future COVID-19 cases under a variety of immune responses, and with or without vaccines